PCP
MCRB icon

Proficio Capital Partners’s Seres Therapeutics MCRB Stock Holding History

Proficio Capital Partners’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-17
Closed -$1K – 949
2019
Q2 		$1K Buy
+17
New +$1.61K ﹤0.01% 1755

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Proficio Capital Partners's MCRB Position: Q3 2019 in Review

Proficio Capital Partners sold out of Seres Therapeutics (MCRB) in Q3 2019, closing a stake of 17 shares — an estimated $1K sold.

Proficio Capital Partners first reported a position in MCRB in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 77 funds tracked by Wall St. Rank hold MCRB as of Q3 2019.

  • Proficio Capital Partners reported no remaining Seres Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 17 Seres Therapeutics shares in Q3 2019, an estimated $1K.
  • Proficio Capital Partners first reported a position in Seres Therapeutics in Q2 2019 and held it in 1 quarter.
  • Proficio Capital Partners's Seres Therapeutics position peaked at $1K in Q2 2019.
  • 77 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.